VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.6698
+0.0022 (0.33%)
At close: Jul 7, 2026, 4:00 PM EDT
0.6600
-0.0098 (-1.46%)
After-hours: Jul 7, 2026, 7:55 PM EDT
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $22.34 million as of July 7, 2026. Its market cap has increased by 50.62% in one year.
Market Cap
22.34M
Enterprise Value
-2.59M
1-Year Change
50.62%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $22.34M, a decrease of -90.28%. That is a compound annual growth rate of -30.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 22.34M | 15.69% |
| Dec 31, 2025 | 19.31M | -60.93% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Barinthus Biotherapeutics | 25.33M |
| NeuroSense Therapeutics | 25.03M |
| Skye Bioscience | 24.62M |
| Marker Therapeutics | 24.51M |
| Tevogen Bio Holdings | 24.16M |
| Pluri | 22.77M |
| Cellectar Biosciences | 22.46M |
| Longeveron | 21.51M |